FNBOO
NVO

First National Bank of Omaha’s Novo Nordisk NVO Stock Holding History

First National Bank of Omaha’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-33,920
Closed -$526 – 393
2013
Q2 		$526 Buy
+33,920
New +$565K 0.04% 262

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SF
Sarofim Fayez Houston, Texas $20.5B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First National Bank of Omaha's NVO Position: Q3 2013 in Review

First National Bank of Omaha sold out of Novo Nordisk (NVO) in Q3 2013, closing a stake of 33,920 shares — an estimated $526 sold.

First National Bank of Omaha first reported a position in NVO in Q2 2013 and held it in 1 quarter. The position peaked at $526 in Q2 2013. 425 funds tracked by Wall St. Rank hold NVO as of Q3 2013.

  • First National Bank of Omaha reported no remaining Novo Nordisk position as of Q3 2013 after selling out during the quarter.
  • First National Bank of Omaha sold 33,920 Novo Nordisk shares in Q3 2013, an estimated $526.
  • First National Bank of Omaha first reported a position in Novo Nordisk in Q2 2013 and held it in 1 quarter.
  • First National Bank of Omaha's Novo Nordisk position peaked at $526 in Q2 2013.
  • 425 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2013.

Based on First National Bank of Omaha's 13F filing for Q3 2013, filed 12 Nov 2013.